TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
Synthetic Biology Market Forecast Report to 2029: Focus on Market Opportunities - Use of Machine Learning in Synthetic Biology and Increasing Demand for Fuel Alternatives
September 16, 2024 08:26 ET
|
Research and Markets
Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The "Synthetic Biology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for synthetic biology was valued...
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
August 15, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
Global Oligonucleotide Synthesis Industry Research 2024-2035: Partnerships and Collaborations Fueling Market Growth, Close to 300 Trials Being Evaluated to Treat Myriad of Disease Indications
July 16, 2024 04:01 ET
|
Research and Markets
Dublin, July 16, 2024 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market: Industry Trends and Global Forecasts, Till 2035 - Application Area, Type of Product Synthesized, Type of...
Global Large Molecule Bioanalytical Technologies Market Research 2024: Innovative Analytical Techniques Driving Progress, Integration of AI in Bioanalysis - Forecasts to 2031
June 27, 2024 06:58 ET
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Large Molecule Bioanalytical Technologies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...
Exosome Therapeutics Pipeline research 2024
June 19, 2024 07:45 ET
|
Research and Markets
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "Exosomes - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.An array of drugs is currently moving through various...
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15, 2024 09:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
March 28, 2024 08:30 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
$75+ Billion In Vitro Diagnostic (IVD) Reagents Markets: Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes - Global Forecast to 2030
March 01, 2024 03:46 ET
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry,...
Oligonucleotide Synthesis Market Poised for Exponential Growth in Healthcare and High-Tech Applications - New Research Report Forecasts 2023-2027 Trends and Insights
February 26, 2024 03:19 ET
|
Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027" report...